由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
_pennystock版 - how is acad? Biofish, we need your expertise.
相关主题
HGSI FDA meeting (转载)AMRN halted
ARNABpax
arna一个小生拉AEZS
DCTHDelcath Systems (Nasdaq: DCTH)
VVUS panel discussionDCTH
ARNA 怎么回事?DCTH Complete NDA Submission to the FDA for the Chemosaturation Delivery System
ACADDCTH 戳破50MA 准备上去了?
SPPIDCTH NDA process was delayed as FDA refused to file their NDA
相关话题的讨论汇总
话题: biofish话题: acad话题: expertise话题: your话题: need
1 (共1页)
a****g
发帖数: 8131
1
thanks
b*****h
发帖数: 783
2
The result of its phase3 trial, which is expected in Nov, is critical for
its price, good data can pump it more than double. As this trial is re-
design after the failure of the previous one, nobody knows what it's gonna
be.
However, the odds of success is more than 50%.
Downside, if the trial fails again, acad is on the way to bankruptcy.

【在 a****g 的大作中提到】
: thanks
j*****2
发帖数: 306
3
said said DCTH? what is the CATS here, and the date ???

gonna

【在 b*****h 的大作中提到】
: The result of its phase3 trial, which is expected in Nov, is critical for
: its price, good data can pump it more than double. As this trial is re-
: design after the failure of the previous one, nobody knows what it's gonna
: be.
: However, the odds of success is more than 50%.
: Downside, if the trial fails again, acad is on the way to bankruptcy.

j*****2
发帖数: 306
4
can DCTH be next ARNA??
while no one like it???

gonna

【在 b*****h 的大作中提到】
: The result of its phase3 trial, which is expected in Nov, is critical for
: its price, good data can pump it more than double. As this trial is re-
: design after the failure of the previous one, nobody knows what it's gonna
: be.
: However, the odds of success is more than 50%.
: Downside, if the trial fails again, acad is on the way to bankruptcy.

b*****h
发帖数: 783
5
CAT is FDA accept for reviewing ( priority or standard, we will know it in
10 days), The first bubble is busted when FDA refused reviewing.
I dont know where it can go. but if it can stay on the way as it planed, the
price can recover a lot.

【在 j*****2 的大作中提到】
: said said DCTH? what is the CATS here, and the date ???
:
: gonna

g*********1
发帖数: 725
6
Biofish, you are really bio-stock master. the two ones you said before are
the best in my watch list. :-)

the

【在 b*****h 的大作中提到】
: CAT is FDA accept for reviewing ( priority or standard, we will know it in
: 10 days), The first bubble is busted when FDA refused reviewing.
: I dont know where it can go. but if it can stay on the way as it planed, the
: price can recover a lot.

b*****h
发帖数: 783
7
hehe, dont take that too seriously, biotechs jump and tank frequently.. risk
control should be always in mind.

are

【在 g*********1 的大作中提到】
: Biofish, you are really bio-stock master. the two ones you said before are
: the best in my watch list. :-)
:
: the

g*********1
发帖数: 725
8
Is your backgroud bio related? or you just like bio-stocks and spend a lot
of time to study it ?

risk

【在 b*****h 的大作中提到】
: hehe, dont take that too seriously, biotechs jump and tank frequently.. risk
: control should be always in mind.
:
: are

b*****h
发帖数: 783
9
yes, i have bioscience background..

【在 g*********1 的大作中提到】
: Is your backgroud bio related? or you just like bio-stocks and spend a lot
: of time to study it ?
:
: risk

j*****2
发帖数: 306
10
did I crash ACAD again??
I sold at 2.95 this morning..

【在 b*****h 的大作中提到】
: yes, i have bioscience background..
1 (共1页)
相关主题
DCTH NDA process was delayed as FDA refused to file their NDAVVUS panel discussion
DCTH怎么了?ARNA 怎么回事?
dcth 主贴ACAD
老牛, 觉得 CORT怎么样, 有前途吗?SPPI
HGSI FDA meeting (转载)AMRN halted
ARNABpax
arna一个小生拉AEZS
DCTHDelcath Systems (Nasdaq: DCTH)
相关话题的讨论汇总
话题: biofish话题: acad话题: expertise话题: your话题: need